Sustainability Environment

Thousands of the first genetically modified mosquitoes to be released in Florida

Story at a glance

  • Female aedes aegypti, a species of mosquito, can carry disease, including dengue, yellow fever, Zika and chikungunya.
  • As part of public health efforts against a dengue outbreak in Florida, lawmakers have approved a new project to eliminate the female mosquitoes entirely.
  • The release of genetically modified mosquitoes in the Florida Keys has been met with pushback from some residents.

The first signs of summer are quickly overshadowed once mosquitoes return in many parts of the United States. But a new experiment in Florida might spell the end for the blood-thirsty suckers. 

Mosquito lovers (if you exist), don’t worry, the species isn’t going to disappear entirely. Instead, the male Aedes aegypti has been modified to only create live male offspring, which don’t bite, when mating in the wild with female mosquitoes, which do bite. 


READ MORE STORIES FROM CHANGING AMERICA

RESEARCHERS MAKE SUTURES INSPIRED BY HUMAN TENDONS

IN A BREAKTHROUGH RESEARCHERS IDENTIFY CANCER CELLS BY THEIR ACIDITY

COMBINATION OF DRUGS PROMISING FOR BRAIN TUMOR TREATMENT

NEW BIOINK GETS SCIENTISTS CLOSER TO BEING ABLE TO PRINT HUMAN ORGANS


The Florida Keys Mosquito Control District approved Oxitec’s proposal to release these mosquitoes into the wild under an experimental use permit, targeting the invasive species that can carry dengue, yellow fever, Zika and chikungunya and is already developing a tolerance for many pesticides.

Oxitec will release 12,000 mosquitoes per week for 12 weeks, totaling 144,000. The biotech company has permission to release 750 million mosquitoes, but does not plan to get close to that amount. 

“We are in need of new tools to combat this mosquito,” said Andrea Leal, executive director of the Florida Keys Mosquito Control District. “And given the unique ecosystem we live in, those tools need to be safe, environmentally friendly, and targeted. That is why we are collaborating with Oxitec on this project.”

The project, which has been approved by the Environmental Protection Agency (EPA), Centers for Disease Control and Prevention (CDC) and the Florida Department of Health, targets the carriers after an outbreak of dengue fever hit the region last summer. Small, focused projects will begin this month in a select number of neighborhoods between mile markers 10 and 93 in the Florida Keys, where residents are being asked to host mosquito release boxes or mosquito traps. 


America is changing faster than ever! Add Changing America to your Facebook or Twitter feed to stay on top of the news.


“We’re looking forward to working hand-in-hand with the Keys community to demonstrate the effectiveness of our safe, sustainable technology in light of the growing challenges controlling this disease-spreading mosquito,” said Grey Frandsen, CEO of Oxitec, in a release last August

But not all residents are on board. In February, about two dozen protesters demonstrated against the genetically-modified insects, reported the Miami Herald, and questioned the company’s success. 

Last year, similar mosquitoes were released in Indaiatuba, Brazil, as part of public health efforts against dengue and suppressed up to 95 percent of disease-carrying Aedes aegypti, according to the company. But emails obtained by an activist group reportedly found that much of one government paper reporting a 62 percent suppression rate was written by Oxitec. 

Editor’s note: This article was updated to reflect that 144,000 mosquitoes are expected to be released in 12 weeks, and Oxitec does not plan on releasing the 750 million allowed under the EPA permit. 


WHAT YOU NEED TO KNOW ABOUT CORONAVIRUS RIGHT NOW

IVANKA TRUMP’S VACCINATION SPARKS BACKLASH AMONG HER FANS

MODERNA SAYS ITS BOOSTER SHOT AGAINST COVID-19 COULD BE AVAILABLE BY THE FALL

DENMARK PERMANENTLY STOPS USE OF ASTRAZENECA VACCINE

FAUCI EXPLAINS HOW YOU CAN GET COVID-19 EVEN AFTER YOU’VE BEEN VACCINATED

TRUMP’S CDC DIRECTOR JOINS BIG ASS FANS COMPANY, WHICH CLAIMS ITS PRODUCT KILLS CORONAVIRUS

US CALLS TO SUSPEND USE OF J&J VACCINE AFTER BLOOD CLOTTING PROBLEMS


 


Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.